Pseudomonas cepacia endocarditis treated with co-trimoxazole and kanamycin.
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D004357:Drug Synergism; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D007612:Kanamycin; D014295:Trimethoprim; D013420:Sulfamethoxazole